CVAA489

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CVAA489, covering 2017-03-28 to 2017-03-28. Get the full timeline:

Most recent: Clinical Trial Update: Study of Efficacy and Safety of CVAA489 in Hypertensive Patients [Phase 4]